Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-14.42	14.06	16.43
Graham Fair Price	52.36	6.89	4.52
PEG	-71.77	-0.01	0.05
Price/Book	6.54	1.05	0.98
Price/Cash Flow	47.40	-29.69	20.14
Prices/Earnings	-46.94	4.59	-8.66
Price/Sales	13.38	1.04	0.92
Price/FCF	47.40	-29.69	20.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	31.08	0.27	0.20
Operating Margin	129.98	0.10	0.04
ROA	93.37	0.01	< 0.005
ROE	-0.03	0.06	100.77
ROIC	0.02	0.03	53.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.51	0.03	1796.22
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.47	1.32	179.16
EPS QOQ	-1.70	3.19	87.98
FCF QOQ	0.01	-1.78	16072.28
Revenue QOQ	< 0.005	0.01	122.09
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.52	93.84	19.51
Days Sales Outstanding (DSO)	66.05	62.72	-5.03
Inventory Turnover	1.15	0.96	-16.32
Debt/Capitalization	0.52	0.60	16.72
Quick Ratio	0.77	0.94	22.38
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.66	6.09	7.53
Cash	1.64	2.52	53.57
Capex	-0.41	-0.33	18.68
Free Cash Flow	0.28	-0.21	-22.28
Revenue	6.07	6.13	1.04
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.33	1.68	26.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.90	7.50	-4.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating